Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...